1. Cell Res. 2022 Mar;32(3):319-321. doi: 10.1038/s41422-022-00619-9. Epub 2022
Jan  21.

Reduced interferon antagonism but similar drug sensitivity in Omicron variant 
compared to Delta variant of SARS-CoV-2 isolates.

Bojkova D(1), Widera M(1), Ciesek S(1)(2)(3), Wass MN(4), Michaelis M(5), Cinatl 
J Jr(6)(7).

Author information:
(1)Institute for Medical Virology, University Hospital, Goethe University, 
Frankfurt am Main, Germany.
(2)German Center for Infection Research, DZIF, External Partner Site Frankfurt 
am Main, Frankfurt am Main, Germany.
(3)Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch 
Translational Medicine und Pharmacology, Frankfurt am Main, Germany.
(4)School of Biosciences, University of Kent, Canterbury, UK. 
M.N.Wass@kent.ac.uk.
(5)School of Biosciences, University of Kent, Canterbury, UK. 
M.Michaelis@kent.ac.uk.
(6)Institute for Medical Virology, University Hospital, Goethe University, 
Frankfurt am Main, Germany. Cinatl@em.uni-frankfurt.de.
(7)Dr. Petra Joh-Forschungshaus, Frankfurt am Main, Germany. 
Cinatl@em.uni-frankfurt.de.

Comment in
    Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2203753119. doi: 
10.1073/pnas.2203753119.

DOI: 10.1038/s41422-022-00619-9
PMCID: PMC8781709
PMID: 35064226 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no competing interests.